Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of respiratory burst (GO:0060267) | 8.11750598 |
2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 7.67325728 |
3 | B cell receptor signaling pathway (GO:0050853) | 7.14886304 |
4 | * Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 7.06625362 |
5 | * immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 7.06625362 |
6 | * Fc-gamma receptor signaling pathway (GO:0038094) | 7.06625362 |
7 | glomerular filtration (GO:0003094) | 7.00877137 |
8 | * Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 6.96762158 |
9 | * protein activation cascade (GO:0072376) | 6.69139272 |
10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.55272358 |
11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.55272358 |
12 | renal filtration (GO:0097205) | 6.33832921 |
13 | positive regulation of B cell differentiation (GO:0045579) | 6.11700641 |
14 | * humoral immune response (GO:0006959) | 6.06249947 |
15 | negative regulation of B cell proliferation (GO:0030889) | 5.84496878 |
16 | regulation of B cell differentiation (GO:0045577) | 5.73026793 |
17 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.72888829 |
18 | cellular response to zinc ion (GO:0071294) | 5.56495646 |
19 | regulation of respiratory burst (GO:0060263) | 5.46583083 |
20 | negative regulation of glucose import (GO:0046325) | 5.11100533 |
21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.08406835 |
22 | regulation of B cell proliferation (GO:0030888) | 4.98399327 |
23 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 4.93440800 |
24 | cytidine deamination (GO:0009972) | 4.88541177 |
25 | cytidine metabolic process (GO:0046087) | 4.88541177 |
26 | cytidine catabolic process (GO:0006216) | 4.88541177 |
27 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.64044684 |
28 | regulation of cellular extravasation (GO:0002691) | 4.60544023 |
29 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 4.60450973 |
30 | immunoglobulin mediated immune response (GO:0016064) | 4.30844523 |
31 | positive regulation of antigen processing and presentation (GO:0002579) | 4.30045221 |
32 | mature B cell differentiation (GO:0002335) | 4.27660376 |
33 | negative regulation of glucose transport (GO:0010829) | 4.21149200 |
34 | detection of bacterium (GO:0016045) | 4.14381680 |
35 | positive regulation of Rap GTPase activity (GO:0032854) | 4.11984604 |
36 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.09159523 |
37 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.07565211 |
38 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.06870723 |
39 | detection of other organism (GO:0098543) | 4.00181346 |
40 | negative regulation of cell killing (GO:0031342) | 3.91089078 |
41 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.91089078 |
42 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.89981508 |
43 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.79544965 |
44 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.78604339 |
45 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.78604339 |
46 | B cell proliferation (GO:0042100) | 3.74267714 |
47 | positive thymic T cell selection (GO:0045059) | 3.70029292 |
48 | cellular response to type I interferon (GO:0071357) | 3.69953928 |
49 | type I interferon signaling pathway (GO:0060337) | 3.69953928 |
50 | response to type I interferon (GO:0034340) | 3.69829036 |
51 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.65002683 |
52 | regulation of gamma-delta T cell activation (GO:0046643) | 3.64001430 |
53 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.61556827 |
54 | regulation of antigen processing and presentation (GO:0002577) | 3.56668841 |
55 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.56161221 |
56 | positive regulation of immunoglobulin production (GO:0002639) | 3.55530853 |
57 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.52657495 |
58 | regulation of B cell activation (GO:0050864) | 3.48874661 |
59 | B cell homeostasis (GO:0001782) | 3.47623831 |
60 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.47176240 |
61 | thymic T cell selection (GO:0045061) | 3.45313949 |
62 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.44422827 |
63 | positive regulation of pseudopodium assembly (GO:0031274) | 3.43742865 |
64 | regulation of Rap GTPase activity (GO:0032317) | 3.43266056 |
65 | negative thymic T cell selection (GO:0045060) | 3.42593934 |
66 | * immune response-activating signal transduction (GO:0002757) | 3.41845633 |
67 | Fc-epsilon receptor signaling pathway (GO:0038095) | 3.40463088 |
68 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.39341626 |
69 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.39125311 |
70 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.37904493 |
71 | respiratory burst (GO:0045730) | 3.37550015 |
72 | angiotensin maturation (GO:0002003) | 3.36902311 |
73 | germinal center formation (GO:0002467) | 3.36781519 |
74 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.29933958 |
75 | cellular response to interferon-gamma (GO:0071346) | 3.29847011 |
76 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.29259938 |
77 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.25440252 |
78 | * immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 3.25076455 |
79 | regulation of B cell apoptotic process (GO:0002902) | 3.24630716 |
80 | B cell mediated immunity (GO:0019724) | 3.22494281 |
81 | chronic inflammatory response (GO:0002544) | 3.22195342 |
82 | maternal placenta development (GO:0001893) | 3.18485448 |
83 | response to interleukin-15 (GO:0070672) | 3.16392336 |
84 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.16164686 |
85 | T-helper 1 type immune response (GO:0042088) | 3.14741151 |
86 | negative T cell selection (GO:0043383) | 3.12882323 |
87 | response to interferon-gamma (GO:0034341) | 3.11145641 |
88 | T cell selection (GO:0045058) | 3.10694578 |
89 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.09948048 |
90 | * activation of immune response (GO:0002253) | 3.09360050 |
91 | regulation of superoxide anion generation (GO:0032928) | 3.09041551 |
92 | myeloid dendritic cell differentiation (GO:0043011) | 3.08173782 |
93 | positive regulation of B cell activation (GO:0050871) | 3.07959658 |
94 | mature B cell differentiation involved in immune response (GO:0002313) | 3.07636951 |
95 | regulation of integrin activation (GO:0033623) | 3.07541493 |
96 | * Fc receptor signaling pathway (GO:0038093) | 3.07096589 |
97 | regulation of pseudopodium assembly (GO:0031272) | 3.06223210 |
98 | T cell costimulation (GO:0031295) | 3.05962045 |
99 | signal peptide processing (GO:0006465) | 3.02955548 |
100 | NIK/NF-kappaB signaling (GO:0038061) | 3.02900315 |
101 | positive regulation of B cell proliferation (GO:0030890) | 3.02876052 |
102 | detection of external biotic stimulus (GO:0098581) | 3.00448665 |
103 | B cell activation (GO:0042113) | 2.99222531 |
104 | lymphocyte costimulation (GO:0031294) | 2.97911686 |
105 | lymphocyte homeostasis (GO:0002260) | 2.97723847 |
106 | antimicrobial humoral response (GO:0019730) | 2.97284401 |
107 | dendritic cell chemotaxis (GO:0002407) | 2.95201974 |
108 | negative regulation of B cell activation (GO:0050869) | 2.93633233 |
109 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.90111177 |
110 | antibacterial humoral response (GO:0019731) | 2.90044083 |
111 | negative regulation of phagocytosis (GO:0050765) | 2.86753051 |
112 | regulation of nuclease activity (GO:0032069) | 2.86739783 |
113 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.85887398 |
114 | positive regulation of nuclease activity (GO:0032075) | 2.85095358 |
115 | regulation of T cell tolerance induction (GO:0002664) | 2.81122814 |
116 | surfactant homeostasis (GO:0043129) | 2.79931310 |
117 | myeloid dendritic cell activation (GO:0001773) | 2.79818219 |
118 | bone resorption (GO:0045453) | 2.77078422 |
119 | production of molecular mediator of immune response (GO:0002440) | 2.77000224 |
120 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.76959344 |
121 | positive regulation of neutrophil migration (GO:1902624) | 2.76959344 |
122 | fucose catabolic process (GO:0019317) | 2.76926607 |
123 | L-fucose metabolic process (GO:0042354) | 2.76926607 |
124 | L-fucose catabolic process (GO:0042355) | 2.76926607 |
125 | defense response to Gram-negative bacterium (GO:0050829) | 2.75629043 |
126 | positive regulation of interleukin-2 production (GO:0032743) | 2.75503929 |
127 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 2.74875632 |
128 | cellular response to interleukin-15 (GO:0071350) | 2.74704505 |
129 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.74401825 |
130 | * retina homeostasis (GO:0001895) | 2.74100108 |
131 | peptide catabolic process (GO:0043171) | 2.73524920 |
132 | N-acetylneuraminate metabolic process (GO:0006054) | 2.72849353 |
133 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.72258156 |
134 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.71625895 |
135 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.71416382 |
136 | positive regulation of T cell migration (GO:2000406) | 2.71054688 |
137 | regulation of T cell migration (GO:2000404) | 2.64967995 |
138 | defense response to protozoan (GO:0042832) | 2.62153168 |
139 | virion attachment to host cell (GO:0019062) | 2.59530669 |
140 | adhesion of symbiont to host cell (GO:0044650) | 2.59530669 |
141 | eosinophil chemotaxis (GO:0048245) | 2.55330651 |
142 | detection of biotic stimulus (GO:0009595) | 2.53120076 |
143 | regulation of tolerance induction (GO:0002643) | 2.50919360 |
144 | protein-chromophore linkage (GO:0018298) | 2.50075885 |
145 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.47520278 |
146 | positive regulation of lymphocyte migration (GO:2000403) | 2.47423228 |
147 | positive regulation of lipid kinase activity (GO:0090218) | 2.46720510 |
148 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.46075190 |
149 | positive regulation of type 2 immune response (GO:0002830) | 2.46023213 |
150 | interferon-gamma secretion (GO:0072643) | 2.43973316 |
151 | dendritic cell differentiation (GO:0097028) | 2.42855055 |
152 | regulation of necrotic cell death (GO:0010939) | 2.42811847 |
153 | dendritic cell migration (GO:0036336) | 2.42305270 |
154 | regulation of regulatory T cell differentiation (GO:0045589) | 2.41602114 |
155 | positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552) | 2.37719247 |
156 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.37216636 |
157 | eosinophil migration (GO:0072677) | 2.35914772 |
158 | regulation of lymphocyte migration (GO:2000401) | 2.34961511 |
159 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.34309654 |
160 | GDP-mannose metabolic process (GO:0019673) | 2.33581019 |
161 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.33527517 |
162 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.33354009 |
163 | modulation by symbiont of host immune response (GO:0052553) | 2.33354009 |
164 | * complement activation, classical pathway (GO:0006958) | 14.0569596 |
165 | * complement activation (GO:0006956) | 10.6531904 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.01310673 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.05494098 |
3 | MYC_22102868_ChIP-Seq_BL_Human | 4.99438021 |
4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.85410565 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.67779671 |
6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.09070173 |
7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.88594120 |
8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.81928991 |
9 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.73811302 |
10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.71668430 |
11 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.52308945 |
12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.39956454 |
13 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.12159577 |
14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.11060892 |
15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.02445732 |
16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.85655078 |
17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.72390182 |
18 | MAF_26560356_Chip-Seq_TH1_Human | 2.71638778 |
19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.61396593 |
20 | MYB_26560356_Chip-Seq_TH2_Human | 2.57898316 |
21 | MYB_26560356_Chip-Seq_TH1_Human | 2.55269596 |
22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.42950443 |
23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.39091583 |
24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.27381491 |
25 | UTX_26944678_Chip-Seq_JUKART_Human | 2.25749597 |
26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.21504423 |
27 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.18490701 |
28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.15708128 |
29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.15614021 |
30 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.11116828 |
31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05943080 |
32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.03861606 |
33 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.96990857 |
34 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.93739633 |
35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.84845092 |
36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.82622327 |
37 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.79642627 |
38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.79278749 |
39 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.76563851 |
40 | MAF_26560356_Chip-Seq_TH2_Human | 1.69655586 |
41 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.67938482 |
42 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.65752201 |
43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.65605137 |
44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.65241880 |
45 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.64989643 |
46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.64175857 |
47 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.63272152 |
48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.62097366 |
49 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.60184841 |
50 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.55336634 |
51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.54278170 |
52 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53881131 |
53 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.52895084 |
54 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.52805872 |
55 | SPI1_23127762_ChIP-Seq_K562_Human | 1.50739845 |
56 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.49677964 |
57 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.49389086 |
58 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49367859 |
59 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.49276812 |
60 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48576731 |
61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.44895595 |
62 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.44128145 |
63 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.39061678 |
64 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.34048037 |
65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31935175 |
66 | GATA3_26560356_Chip-Seq_TH2_Human | 1.31934362 |
67 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.31246386 |
68 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.30239203 |
69 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.29388562 |
70 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.29206763 |
71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28271368 |
72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26018508 |
73 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.25906650 |
74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19953334 |
75 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19813399 |
76 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.19786834 |
77 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.19784042 |
78 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18790638 |
79 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.16041559 |
80 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.15652373 |
81 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15644442 |
82 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.14104699 |
83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13165685 |
84 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.09141594 |
85 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.08357638 |
86 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.07449279 |
87 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07105839 |
88 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06234892 |
89 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.05242742 |
90 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.04310097 |
91 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.03553140 |
92 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02455481 |
93 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01499300 |
94 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01320913 |
95 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00041973 |
96 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00020249 |
97 | P300_27268052_Chip-Seq_Bcells_Human | 0.99813933 |
98 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99712705 |
99 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.98402168 |
100 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97930916 |
101 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97488228 |
102 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.96803756 |
103 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96742171 |
104 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.96094283 |
105 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96066815 |
106 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95274459 |
107 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94818263 |
108 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.93210005 |
109 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.92235164 |
110 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92115853 |
111 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.92053867 |
112 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91932523 |
113 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.91539530 |
114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90913021 |
115 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.90893579 |
116 | GATA3_26560356_Chip-Seq_TH1_Human | 0.89649253 |
117 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89274279 |
118 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.89176260 |
119 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.88019754 |
120 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87782829 |
121 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.87747847 |
122 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.87422103 |
123 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.87383222 |
124 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.87022043 |
125 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.86284365 |
126 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83448023 |
127 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82249618 |
128 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.81777570 |
129 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81643274 |
130 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81292208 |
131 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.80972140 |
132 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80168145 |
133 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78786782 |
134 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.76347325 |
135 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75635222 |
136 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75577990 |
137 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74272409 |
138 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.74206352 |
139 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.71450875 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 5.55048164 |
2 | MP0001800_abnormal_humoral_immune | 4.92019268 |
3 | MP0003303_peritoneal_inflammation | 4.68009847 |
4 | MP0003724_increased_susceptibility_to | 4.39272186 |
5 | MP0001790_abnormal_immune_system | 4.30416136 |
6 | MP0005387_immune_system_phenotype | 4.30416136 |
7 | MP0000685_abnormal_immune_system | 3.94753630 |
8 | MP0002452_abnormal_antigen_presenting | 3.65337963 |
9 | MP0005671_abnormal_response_to | 3.12660383 |
10 | MP0002723_abnormal_immune_serum | 3.08327363 |
11 | MP0002420_abnormal_adaptive_immunity | 2.97884909 |
12 | MP0005000_abnormal_immune_tolerance | 2.95871412 |
13 | MP0001819_abnormal_immune_cell | 2.91128075 |
14 | MP0002398_abnormal_bone_marrow | 2.79044069 |
15 | MP0000716_abnormal_immune_system | 2.65825795 |
16 | MP0003300_gastrointestinal_ulcer | 2.54690047 |
17 | MP0000689_abnormal_spleen_morphology | 2.46896974 |
18 | MP0009333_abnormal_splenocyte_physiolog | 2.25584700 |
19 | MP0005025_abnormal_response_to | 2.24228546 |
20 | MP0003763_abnormal_thymus_physiology | 2.23155459 |
21 | MP0002429_abnormal_blood_cell | 2.18969917 |
22 | MP0005166_decreased_susceptibility_to | 2.02479837 |
23 | MP0002722_abnormal_immune_system | 2.00322614 |
24 | MP0003436_decreased_susceptibility_to | 1.98225983 |
25 | MP0002166_altered_tumor_susceptibility | 1.98171480 |
26 | MP0004782_abnormal_surfactant_physiolog | 1.97845933 |
27 | MP0004510_myositis | 1.95284803 |
28 | MP0002148_abnormal_hypersensitivity_rea | 1.94443933 |
29 | MP0001879_abnormal_lymphatic_vessel | 1.93103071 |
30 | MP0001873_stomach_inflammation | 1.92556694 |
31 | MP0006054_spinal_hemorrhage | 1.91295520 |
32 | MP0005275_abnormal_skin_tensile | 1.89343977 |
33 | MP0002419_abnormal_innate_immunity | 1.86894944 |
34 | MP0004858_abnormal_nervous_system | 1.86662976 |
35 | MP0001845_abnormal_inflammatory_respons | 1.85143790 |
36 | MP0002405_respiratory_system_inflammati | 1.78976464 |
37 | MP0010234_abnormal_vibrissa_follicle | 1.65349171 |
38 | MP0002138_abnormal_hepatobiliary_system | 1.65272291 |
39 | MP0010155_abnormal_intestine_physiology | 1.62457379 |
40 | MP0008057_abnormal_DNA_replication | 1.57581669 |
41 | MP0005310_abnormal_salivary_gland | 1.53848361 |
42 | MP0004947_skin_inflammation | 1.52063735 |
43 | MP0009840_abnormal_foam_cell | 1.47216772 |
44 | MP0002006_tumorigenesis | 1.46435689 |
45 | MP0002396_abnormal_hematopoietic_system | 1.45778556 |
46 | MP0009785_altered_susceptibility_to | 1.44396136 |
47 | MP0005360_urolithiasis | 1.42446074 |
48 | MP0000465_gastrointestinal_hemorrhage | 1.41906704 |
49 | MP0003075_altered_response_to | 1.37203980 |
50 | MP0008438_abnormal_cutaneous_collagen | 1.33738107 |
51 | MP0003045_fibrosis | 1.29735737 |
52 | MP0000703_abnormal_thymus_morphology | 1.28116057 |
53 | MP0008004_abnormal_stomach_pH | 1.27848066 |
54 | MP0000604_amyloidosis | 1.27282193 |
55 | MP0003448_altered_tumor_morphology | 1.27134334 |
56 | MP0000343_altered_response_to | 1.26202847 |
57 | MP0002796_impaired_skin_barrier | 1.25941699 |
58 | MP0005464_abnormal_platelet_physiology | 1.25778752 |
59 | MP0005023_abnormal_wound_healing | 1.25365819 |
60 | MP0003279_aneurysm | 1.25093195 |
61 | MP0001853_heart_inflammation | 1.24187346 |
62 | MP0003183_abnormal_peptide_metabolism | 1.21849702 |
63 | MP0003866_abnormal_defecation | 1.16708611 |
64 | MP0009278_abnormal_bone_marrow | 1.16052673 |
65 | MP0004264_abnormal_extraembryonic_tissu | 1.15628807 |
66 | MP0002019_abnormal_tumor_incidence | 1.14443461 |
67 | MP0002933_joint_inflammation | 1.14372864 |
68 | MP0003329_amyloid_beta_deposits | 1.09194133 |
69 | MP0002136_abnormal_kidney_physiology | 1.08932690 |
70 | MP0000858_altered_metastatic_potential | 1.08010662 |
71 | MP0001666_abnormal_nutrient_absorption | 1.05235697 |
72 | MP0005503_abnormal_tendon_morphology | 1.05088417 |
73 | MP0003453_abnormal_keratinocyte_physiol | 1.03220386 |
74 | MP0005390_skeleton_phenotype | 1.02844409 |
75 | MP0009764_decreased_sensitivity_to | 1.02077711 |
76 | MP0000249_abnormal_blood_vessel | 0.99696277 |
77 | MP0005409_darkened_coat_color | 0.98508080 |
78 | MP0006082_CNS_inflammation | 0.97954599 |
79 | MP0001851_eye_inflammation | 0.97072357 |
80 | MP0004808_abnormal_hematopoietic_stem | 0.96831340 |
81 | MP0010352_gastrointestinal_tract_polyps | 0.95652000 |
82 | MP0005058_abnormal_lysosome_morphology | 0.92468737 |
83 | MP0005164_abnormal_response_to | 0.91860086 |
84 | MP0008469_abnormal_protein_level | 0.91772201 |
85 | MP0002139_abnormal_hepatobiliary_system | 0.90441384 |
86 | MP0008260_abnormal_autophagy | 0.89468342 |
87 | MP0002254_reproductive_system_inflammat | 0.87502708 |
88 | MP0001663_abnormal_digestive_system | 0.86255853 |
89 | MP0002277_abnormal_respiratory_mucosa | 0.83905653 |
90 | MP0005076_abnormal_cell_differentiation | 0.83385635 |
91 | MP0000681_abnormal_thyroid_gland | 0.78990846 |
92 | MP0000490_abnormal_crypts_of | 0.78202294 |
93 | MP0001664_abnormal_digestion | 0.76932086 |
94 | MP0008961_abnormal_basal_metabolism | 0.76150253 |
95 | MP0002168_other_aberrant_phenotype | 0.74847073 |
96 | MP0005397_hematopoietic_system_phenotyp | 0.74708806 |
97 | MP0001545_abnormal_hematopoietic_system | 0.74708806 |
98 | MP0005451_abnormal_body_composition | 0.73698203 |
99 | MP0001216_abnormal_epidermal_layer | 0.72597319 |
100 | MP0003693_abnormal_embryo_hatching | 0.71572623 |
101 | MP0003566_abnormal_cell_adhesion | 0.69915109 |
102 | MP0001348_abnormal_lacrimal_gland | 0.69884322 |
103 | MP0000609_abnormal_liver_physiology | 0.69601617 |
104 | MP0003091_abnormal_cell_migration | 0.69310294 |
105 | MP0001533_abnormal_skeleton_physiology | 0.68475497 |
106 | MP0003077_abnormal_cell_cycle | 0.67236587 |
107 | MP0002693_abnormal_pancreas_physiology | 0.65540458 |
108 | MP0009643_abnormal_urine_homeostasis | 0.63462716 |
109 | MP0000733_abnormal_muscle_development | 0.60754185 |
110 | MP0001919_abnormal_reproductive_system | 0.60483715 |
111 | MP0000003_abnormal_adipose_tissue | 0.60310729 |
112 | MP0003191_abnormal_cellular_cholesterol | 0.59877120 |
113 | MP0003656_abnormal_erythrocyte_physiolo | 0.59278426 |
114 | MP0003828_pulmonary_edema | 0.57766857 |
115 | MP0008874_decreased_physiological_sensi | 0.56004887 |
116 | MP0002133_abnormal_respiratory_system | 0.55909864 |
117 | MP0005388_respiratory_system_phenotype | 0.55909864 |
118 | MP0010094_abnormal_chromosome_stability | 0.55683718 |
119 | MP0001958_emphysema | 0.55590058 |
120 | MP0002083_premature_death | 0.54277964 |
121 | MP0009763_increased_sensitivity_to | 0.53362376 |
122 | MP0001944_abnormal_pancreas_morphology | 0.51568594 |
123 | MP0005389_reproductive_system_phenotype | 0.51276655 |
124 | MP0002998_abnormal_bone_remodeling | 0.51000667 |
125 | MP0000477_abnormal_intestine_morphology | 0.50470867 |
126 | MP0001730_embryonic_growth_arrest | 0.49105000 |
127 | MP0002928_abnormal_bile_duct | 0.48270485 |
128 | MP0001191_abnormal_skin_condition | 0.48254022 |
129 | MP0002876_abnormal_thyroid_physiology | 0.47340952 |
130 | MP0003787_abnormal_imprinting | 0.47276767 |
131 | MP0008872_abnormal_physiological_respon | 0.46751833 |
132 | MP0000350_abnormal_cell_proliferation | 0.46733773 |
133 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.46431581 |
134 | MP0005621_abnormal_cell_physiology | 0.44995208 |
135 | MP0005381_digestive/alimentary_phenotyp | 0.44762801 |
136 | MP0008569_lethality_at_weaning | 0.44286677 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Agammaglobulinemia (HP:0004432) | 9.83165479 |
2 | Recurrent sinusitis (HP:0011108) | 7.27480099 |
3 | Colitis (HP:0002583) | 7.22924510 |
4 | Cellulitis (HP:0100658) | 7.01689194 |
5 | Abnormality of B cell number (HP:0010975) | 6.95932075 |
6 | B lymphocytopenia (HP:0010976) | 6.95932075 |
7 | Recurrent bronchitis (HP:0002837) | 6.84343212 |
8 | Systemic lupus erythematosus (HP:0002725) | 6.59471319 |
9 | Verrucae (HP:0200043) | 6.24828035 |
10 | Papilloma (HP:0012740) | 6.24828035 |
11 | Gastrointestinal stroma tumor (HP:0100723) | 5.96895922 |
12 | Inflammation of the large intestine (HP:0002037) | 5.83145299 |
13 | IgM deficiency (HP:0002850) | 5.77084627 |
14 | Gastrointestinal inflammation (HP:0004386) | 5.60667095 |
15 | Recurrent viral infections (HP:0004429) | 5.49405653 |
16 | Meningitis (HP:0001287) | 5.07394591 |
17 | Recurrent pneumonia (HP:0006532) | 4.84169565 |
18 | Prostate neoplasm (HP:0100787) | 4.80622867 |
19 | Chronic otitis media (HP:0000389) | 4.77074467 |
20 | Malnutrition (HP:0004395) | 4.74451648 |
21 | Chronic sinusitis (HP:0011109) | 4.46296068 |
22 | Recurrent lower respiratory tract infections (HP:0002783) | 4.36470501 |
23 | Osteomyelitis (HP:0002754) | 4.25349495 |
24 | Abnormality of complement system (HP:0005339) | 4.22575373 |
25 | Emphysema (HP:0002097) | 4.11747357 |
26 | Glomerulonephritis (HP:0000099) | 4.08487485 |
27 | Bronchitis (HP:0012387) | 4.07868960 |
28 | Complement deficiency (HP:0004431) | 3.98217309 |
29 | Recurrent otitis media (HP:0000403) | 3.83617422 |
30 | IgA deficiency (HP:0002720) | 3.73636838 |
31 | Panhypogammaglobulinemia (HP:0003139) | 3.71539738 |
32 | Abnormality of the prostate (HP:0008775) | 3.69941350 |
33 | Sepsis (HP:0100806) | 3.67374787 |
34 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.67220903 |
35 | Lymphopenia (HP:0001888) | 3.50167841 |
36 | Recurrent abscess formation (HP:0002722) | 3.39894004 |
37 | IgG deficiency (HP:0004315) | 3.39360802 |
38 | Nephritis (HP:0000123) | 3.38143995 |
39 | Vasculitis (HP:0002633) | 3.37216936 |
40 | Interstitial pulmonary disease (HP:0006530) | 3.35840667 |
41 | Recurrent fungal infections (HP:0002841) | 3.35059962 |
42 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.34685225 |
43 | Recurrent bacterial skin infections (HP:0005406) | 3.29290512 |
44 | Increased IgE level (HP:0003212) | 3.25011755 |
45 | Thyroiditis (HP:0100646) | 3.11850442 |
46 | Restrictive lung disease (HP:0002091) | 3.10834506 |
47 | Nasal polyposis (HP:0100582) | 3.09994137 |
48 | Eczematoid dermatitis (HP:0000976) | 3.09558570 |
49 | Abnormality of T cell physiology (HP:0011840) | 3.07299124 |
50 | Premature loss of primary teeth (HP:0006323) | 3.05609907 |
51 | Gastrointestinal infarctions (HP:0005244) | 2.96810432 |
52 | Skin rash (HP:0000988) | 2.94021719 |
53 | Chronic diarrhea (HP:0002028) | 2.92947764 |
54 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.80330958 |
55 | Recurrent cutaneous fungal infections (HP:0011370) | 2.80330958 |
56 | Recurrent skin infections (HP:0001581) | 2.80124856 |
57 | Abnormality of T cells (HP:0002843) | 2.80047958 |
58 | Abnormality of the nasal mucosa (HP:0000433) | 2.79072975 |
59 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.73515359 |
60 | Orchitis (HP:0100796) | 2.72288662 |
61 | Hemoptysis (HP:0002105) | 2.72210814 |
62 | Small epiphyses (HP:0010585) | 2.67409747 |
63 | Leukocytosis (HP:0001974) | 2.65254713 |
64 | Mediastinal lymphadenopathy (HP:0100721) | 2.50686196 |
65 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.49396480 |
66 | Abnormality of T cell number (HP:0011839) | 2.48157228 |
67 | T lymphocytopenia (HP:0005403) | 2.45516558 |
68 | Bronchiectasis (HP:0002110) | 2.38861377 |
69 | Alopecia of scalp (HP:0002293) | 2.38699079 |
70 | Skin ulcer (HP:0200042) | 2.35832817 |
71 | Mitral stenosis (HP:0001718) | 2.35819399 |
72 | Purpura (HP:0000979) | 2.29600069 |
73 | Chronic obstructive pulmonary disease (HP:0006510) | 2.26213806 |
74 | Obstructive lung disease (HP:0006536) | 2.26213806 |
75 | Autoimmune thrombocytopenia (HP:0001973) | 2.25031246 |
76 | Optic neuritis (HP:0100653) | 2.23955179 |
77 | Retrobulbar optic neuritis (HP:0100654) | 2.23955179 |
78 | Pustule (HP:0200039) | 2.22830859 |
79 | Abnormality of male internal genitalia (HP:0000022) | 2.21692437 |
80 | Viral hepatitis (HP:0006562) | 2.16903108 |
81 | Spontaneous hematomas (HP:0007420) | 2.15569592 |
82 | Abnormality of the peritoneum (HP:0002585) | 2.10794836 |
83 | Neutropenia (HP:0001875) | 2.10588474 |
84 | Leukopenia (HP:0001882) | 2.10553841 |
85 | Abnormality of the pleura (HP:0002103) | 2.08658261 |
86 | Neoplasm of the lung (HP:0100526) | 2.06519845 |
87 | Lymphoma (HP:0002665) | 2.03542998 |
88 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.03495291 |
89 | Polycythemia (HP:0001901) | 2.03167204 |
90 | Hypermelanotic macule (HP:0001034) | 2.00517528 |
91 | Thrombocytosis (HP:0001894) | 2.00178950 |
92 | Pulmonary infiltrates (HP:0002113) | 1.99993559 |
93 | Abnormality of the fingertips (HP:0001211) | 1.99971898 |
94 | Ankyloglossia (HP:0010296) | 1.99560778 |
95 | Fragile skin (HP:0001030) | 1.97930160 |
96 | Combined immunodeficiency (HP:0005387) | 1.94384957 |
97 | Keratoconjunctivitis sicca (HP:0001097) | 1.94229249 |
98 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.92111483 |
99 | Hemorrhage of the eye (HP:0011885) | 1.92100339 |
100 | Urticaria (HP:0001025) | 1.91089024 |
101 | Dehydration (HP:0001944) | 1.90879688 |
102 | Increased IgM level (HP:0003496) | 1.90151241 |
103 | Pulmonary embolism (HP:0002204) | 1.88432678 |
104 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.86277167 |
105 | Encephalitis (HP:0002383) | 1.84587837 |
106 | Arthralgia (HP:0002829) | 1.82236140 |
107 | Autoimmune hemolytic anemia (HP:0001890) | 1.81812944 |
108 | Atrophic scars (HP:0001075) | 1.81422943 |
109 | Polygenic inheritance (HP:0010982) | 1.80509602 |
110 | Myositis (HP:0100614) | 1.78206518 |
111 | Hematochezia (HP:0002573) | 1.77728441 |
112 | Papilledema (HP:0001085) | 1.77282621 |
113 | Hypergammaglobulinemia (HP:0010702) | 1.73362308 |
114 | Basal cell carcinoma (HP:0002671) | 1.72624718 |
115 | Acrocyanosis (HP:0001063) | 1.67051461 |
116 | Flattened epiphyses (HP:0003071) | 1.65746332 |
117 | Eosinophilia (HP:0001880) | 1.61086539 |
118 | Xerostomia (HP:0000217) | 1.59618402 |
119 | Irregular vertebral endplates (HP:0003301) | 1.57154929 |
120 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.53792426 |
121 | Hepatitis (HP:0012115) | 1.52817375 |
122 | Mucosal telangiectasiae (HP:0100579) | 1.51256023 |
123 | Chest pain (HP:0100749) | 1.48831697 |
124 | Gingivitis (HP:0000230) | 1.47992339 |
125 | Abnormality of macrophages (HP:0004311) | 1.47877339 |
126 | Hypochromic anemia (HP:0001931) | 1.46463678 |
127 | Severe combined immunodeficiency (HP:0004430) | 1.45390980 |
128 | Teleangiectasia of the skin (HP:0100585) | 1.43535437 |
129 | Vertebral arch anomaly (HP:0008438) | 1.40812119 |
130 | Arterial thrombosis (HP:0004420) | 1.40482258 |
131 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.39083489 |
132 | Villous atrophy (HP:0011473) | 1.39083489 |
133 | Erythema (HP:0010783) | 1.38306684 |
134 | Abnormal foot bone ossification (HP:0010675) | 1.37360668 |
135 | Ulnar deviation of the wrist (HP:0003049) | 1.36744546 |
136 | Keratoconjunctivitis (HP:0001096) | 1.36531794 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 6.68837635 |
2 | ERN1 | 6.32180988 |
3 | GRK6 | 3.11026042 |
4 | BLK | 3.02453322 |
5 | CSF1R | 2.73310799 |
6 | SYK | 2.72109058 |
7 | PRPF4B | 2.70206477 |
8 | MST1R | 2.66648078 |
9 | RIPK4 | 2.60969156 |
10 | MAP3K10 | 2.56653191 |
11 | TYK2 | 2.38681118 |
12 | RIPK1 | 2.19402548 |
13 | TAOK3 | 2.11774257 |
14 | STK10 | 2.04055065 |
15 | MAP3K14 | 1.99215273 |
16 | LRRK2 | 1.85899347 |
17 | BTK | 1.81225103 |
18 | SIK2 | 1.73422815 |
19 | PRKCH | 1.69546477 |
20 | KIT | 1.68063601 |
21 | JAK1 | 1.61698956 |
22 | EEF2K | 1.59569918 |
23 | MAP3K13 | 1.51661886 |
24 | IRAK3 | 1.47670576 |
25 | IRAK4 | 1.45213176 |
26 | TXK | 1.42989603 |
27 | LYN | 1.41198698 |
28 | TBK1 | 1.37044424 |
29 | NEK2 | 1.31888188 |
30 | EIF2AK3 | 1.29062540 |
31 | JAK3 | 1.25660016 |
32 | MAP3K1 | 1.25559667 |
33 | HCK | 1.24701769 |
34 | FES | 1.24044099 |
35 | PRKCQ | 1.23277024 |
36 | SMG1 | 1.19506974 |
37 | PDGFRA | 1.17400722 |
38 | TRIB3 | 1.16429081 |
39 | NME2 | 1.14821915 |
40 | ALK | 1.12026177 |
41 | ITK | 1.08748884 |
42 | CSK | 1.07395275 |
43 | HIPK2 | 1.06641401 |
44 | DDR2 | 1.06528682 |
45 | IKBKE | 1.06185673 |
46 | NEK9 | 1.06008609 |
47 | CDK12 | 1.05841677 |
48 | IRAK1 | 1.03795476 |
49 | FGFR4 | 1.03014444 |
50 | IKBKB | 1.02621158 |
51 | MST4 | 1.01277785 |
52 | TGFBR2 | 0.99450867 |
53 | EPHA2 | 0.95265996 |
54 | FGFR3 | 0.94178373 |
55 | PRKG2 | 0.92433027 |
56 | PIM1 | 0.91025025 |
57 | MARK3 | 0.90438933 |
58 | PIK3CA | 0.89803954 |
59 | TAOK1 | 0.89741576 |
60 | FER | 0.88626659 |
61 | LCK | 0.85767637 |
62 | CLK1 | 0.85676244 |
63 | MET | 0.82953871 |
64 | MAP3K3 | 0.82293107 |
65 | EPHB1 | 0.80815669 |
66 | ACVR1B | 0.76995976 |
67 | NLK | 0.75179024 |
68 | MAP3K9 | 0.74916307 |
69 | KSR2 | 0.72122495 |
70 | EPHB2 | 0.71395001 |
71 | ZAP70 | 0.71345240 |
72 | SIK1 | 0.70453211 |
73 | TEC | 0.69469063 |
74 | MAP3K11 | 0.68431764 |
75 | TNK2 | 0.68033058 |
76 | PRKD2 | 0.67229949 |
77 | MATK | 0.64743454 |
78 | SIK3 | 0.63593220 |
79 | RET | 0.61313057 |
80 | PDPK1 | 0.59049683 |
81 | FGR | 0.58477213 |
82 | PRKCI | 0.56999248 |
83 | MAP3K6 | 0.55693933 |
84 | PRKD1 | 0.54845654 |
85 | KDR | 0.54420919 |
86 | CHUK | 0.53709223 |
87 | RPS6KA4 | 0.53663961 |
88 | JAK2 | 0.53633587 |
89 | BMX | 0.53342947 |
90 | PDK1 | 0.52318628 |
91 | TESK2 | 0.50994806 |
92 | DMPK | 0.50514859 |
93 | PIK3CG | 0.50000943 |
94 | CDK4 | 0.49660873 |
95 | YES1 | 0.45648587 |
96 | GRK1 | 0.45563714 |
97 | FYN | 0.43651643 |
98 | PKN2 | 0.43647787 |
99 | MYLK | 0.43530433 |
100 | PDGFRB | 0.43513951 |
101 | TGFBR1 | 0.43360460 |
102 | MAP2K2 | 0.43013440 |
103 | DYRK1B | 0.42575932 |
104 | MAP3K8 | 0.41470490 |
105 | MAPK7 | 0.41422803 |
106 | MAPK12 | 0.41352419 |
107 | BMPR2 | 0.40958395 |
108 | PRKCD | 0.40828370 |
109 | ABL1 | 0.40755718 |
110 | CDC42BPA | 0.40698422 |
111 | MELK | 0.40214477 |
112 | EGFR | 0.39930936 |
113 | GRK5 | 0.38059843 |
114 | TAOK2 | 0.36647735 |
115 | TESK1 | 0.35803390 |
116 | EPHA3 | 0.35021650 |
117 | DYRK3 | 0.33341033 |
118 | STK24 | 0.33031570 |
119 | CDK6 | 0.32321412 |
120 | INSR | 0.32066556 |
121 | CDK9 | 0.31726644 |
122 | MAP3K7 | 0.31596642 |
123 | PTK6 | 0.31133712 |
124 | SRC | 0.31028595 |
125 | MARK2 | 0.29757372 |
126 | MAPK11 | 0.28933366 |
127 | MAP2K3 | 0.25493347 |
128 | SGK3 | 0.24957351 |
129 | BRD4 | 0.24881826 |
130 | BUB1 | 0.23962618 |
131 | FRK | 0.21838454 |
132 | MAPK4 | 0.19019387 |
133 | TTN | 0.18525817 |
134 | MAPKAPK2 | 0.17294659 |
135 | CDC7 | 0.17147930 |
136 | CSNK1A1L | 0.15630797 |
137 | BRSK1 | 0.15626074 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 7.13804198 |
2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.41089847 |
3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 5.29535339 |
4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.46177090 |
5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.31755683 |
6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.75945463 |
7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.74799696 |
8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.32223511 |
9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.14337860 |
10 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.09901148 |
11 | Protein export_Homo sapiens_hsa03060 | 2.02018759 |
12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.01057816 |
13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.99294571 |
14 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.84881171 |
15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.75308263 |
16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.75116111 |
17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.74681365 |
18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.71239920 |
19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.59154884 |
20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.58730430 |
21 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.45234835 |
22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.34968379 |
23 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.32333542 |
24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.29700171 |
25 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.25250254 |
26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.23529841 |
27 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.21775011 |
28 | Tuberculosis_Homo sapiens_hsa05152 | 1.18402101 |
29 | Measles_Homo sapiens_hsa05162 | 1.15307940 |
30 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14979191 |
31 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.12837665 |
32 | Base excision repair_Homo sapiens_hsa03410 | 1.11730932 |
33 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.11519589 |
34 | Phagosome_Homo sapiens_hsa04145 | 1.09450560 |
35 | Asthma_Homo sapiens_hsa05310 | 1.06543886 |
36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.95158738 |
37 | Hepatitis B_Homo sapiens_hsa05161 | 0.94873131 |
38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.91628204 |
39 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.91474052 |
40 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.90269127 |
41 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.89963319 |
42 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.88985733 |
43 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.88330870 |
44 | Malaria_Homo sapiens_hsa05144 | 0.87814814 |
45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.84967824 |
46 | Apoptosis_Homo sapiens_hsa04210 | 0.84911334 |
47 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.83688677 |
48 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.83450445 |
49 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.83120179 |
50 | Shigellosis_Homo sapiens_hsa05131 | 0.82876490 |
51 | Platelet activation_Homo sapiens_hsa04611 | 0.81132360 |
52 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80294919 |
53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.80234073 |
54 | Viral myocarditis_Homo sapiens_hsa05416 | 0.79999024 |
55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.79721254 |
56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79368852 |
57 | Pertussis_Homo sapiens_hsa05133 | 0.78390429 |
58 | Other glycan degradation_Homo sapiens_hsa00511 | 0.77241549 |
59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.76721570 |
60 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.76623454 |
61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.76489832 |
62 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.76051085 |
63 | DNA replication_Homo sapiens_hsa03030 | 0.75756341 |
64 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74803967 |
65 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73345008 |
66 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72135080 |
67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71209953 |
68 | Amoebiasis_Homo sapiens_hsa05146 | 0.71137795 |
69 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.68699727 |
70 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.67728705 |
71 | Influenza A_Homo sapiens_hsa05164 | 0.65830395 |
72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65176350 |
73 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.64255047 |
74 | Mismatch repair_Homo sapiens_hsa03430 | 0.61313253 |
75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.59290164 |
76 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58835552 |
77 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57441648 |
78 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56842113 |
79 | Prion diseases_Homo sapiens_hsa05020 | 0.55816412 |
80 | Insulin resistance_Homo sapiens_hsa04931 | 0.55648798 |
81 | Mineral absorption_Homo sapiens_hsa04978 | 0.53721256 |
82 | Ribosome_Homo sapiens_hsa03010 | 0.52207460 |
83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52142880 |
84 | Allograft rejection_Homo sapiens_hsa05330 | 0.52052351 |
85 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.51595596 |
86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50321237 |
87 | Salmonella infection_Homo sapiens_hsa05132 | 0.49464039 |
88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49313876 |
89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48348270 |
90 | Legionellosis_Homo sapiens_hsa05134 | 0.48239078 |
91 | Lysosome_Homo sapiens_hsa04142 | 0.47178860 |
92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45586120 |
93 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.45163891 |
94 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.44374648 |
95 | Long-term potentiation_Homo sapiens_hsa04720 | 0.44234434 |
96 | Glioma_Homo sapiens_hsa05214 | 0.40851269 |
97 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.40482429 |
98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40440547 |
99 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.40408732 |
100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.40120485 |
101 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.39042793 |
102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38557310 |
103 | Hepatitis C_Homo sapiens_hsa05160 | 0.38111161 |
104 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.37824163 |
105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37471331 |
106 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35509734 |
107 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.34730096 |
108 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.34238564 |
109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33583526 |
110 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.33042914 |
111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32583291 |
112 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.31781176 |
113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.31286248 |
114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.30221347 |
115 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.30130216 |
116 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.29881718 |
117 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.29714357 |
118 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.29652596 |
119 | Histidine metabolism_Homo sapiens_hsa00340 | 0.29630592 |
120 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.28744590 |
121 | Endocytosis_Homo sapiens_hsa04144 | 0.28492325 |
122 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.27886349 |
123 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.26597681 |
124 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.26189694 |
125 | Prostate cancer_Homo sapiens_hsa05215 | 0.25896431 |
126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.25688612 |
127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.25388599 |
128 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.25345615 |
129 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.25341001 |
130 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.24346684 |
131 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.24222165 |
132 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.24065638 |
133 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.21793279 |
134 | ABC transporters_Homo sapiens_hsa02010 | 0.21709279 |
135 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.20952894 |
136 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.20553747 |
137 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.19711968 |
138 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.19340371 |
139 | Colorectal cancer_Homo sapiens_hsa05210 | 0.19183299 |
140 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.18277633 |